First Horizon Advisors Inc. Sells 727 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

First Horizon Advisors Inc. lessened its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 35.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,344 shares of the company’s stock after selling 727 shares during the period. First Horizon Advisors Inc.’s holdings in Bath & Body Works were worth $58,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of BBWI. Commonwealth Equity Services LLC boosted its holdings in shares of Bath & Body Works by 3.3% in the 3rd quarter. Commonwealth Equity Services LLC now owns 11,044 shares of the company’s stock valued at $373,000 after buying an additional 348 shares during the last quarter. Raymond James & Associates grew its position in shares of Bath & Body Works by 1,063.4% in the 3rd quarter. Raymond James & Associates now owns 103,099 shares of the company’s stock valued at $3,485,000 after acquiring an additional 94,237 shares during the period. Forsta AP Fonden increased its stake in shares of Bath & Body Works by 13.4% during the 3rd quarter. Forsta AP Fonden now owns 63,300 shares of the company’s stock worth $2,140,000 after purchasing an additional 7,500 shares during the last quarter. New York State Teachers Retirement System raised its holdings in shares of Bath & Body Works by 3.6% in the 3rd quarter. New York State Teachers Retirement System now owns 241,567 shares of the company’s stock valued at $8,165,000 after purchasing an additional 8,362 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. lifted its stake in Bath & Body Works by 3.2% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 31,138 shares of the company’s stock valued at $1,052,000 after purchasing an additional 955 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. UBS Group raised their price objective on Bath & Body Works from $46.00 to $52.00 and gave the company a “neutral” rating in a research report on Monday, March 4th. BMO Capital Markets lifted their price objective on shares of Bath & Body Works from $48.00 to $50.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Robert W. Baird increased their price objective on shares of Bath & Body Works from $50.00 to $54.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Evercore ISI lifted their target price on shares of Bath & Body Works from $30.00 to $45.00 and gave the stock an “in-line” rating in a report on Friday, March 1st. Finally, Wells Fargo & Company increased their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the company an “equal weight” rating in a report on Wednesday, April 24th. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $46.73.

Bath & Body Works Stock Performance

NYSE:BBWI opened at $47.22 on Wednesday. The company has a market cap of $10.62 billion, a price-to-earnings ratio of 12.26, a PEG ratio of 1.49 and a beta of 1.89. Bath & Body Works, Inc. has a fifty-two week low of $27.30 and a fifty-two week high of $50.34. The stock has a fifty day moving average price of $46.09 and a 200-day moving average price of $41.27.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, February 29th. The company reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The business had revenue of $2.91 billion during the quarter, compared to analysts’ expectations of $2.84 billion. During the same quarter in the prior year, the business posted $1.86 earnings per share. Bath & Body Works’s revenue was up .8% compared to the same quarter last year. Research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 annualized dividend and a yield of 1.69%. Bath & Body Works’s dividend payout ratio is currently 20.78%.

Insiders Place Their Bets

In other news, insider Thomas E. Mazurek sold 4,285 shares of Bath & Body Works stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the transaction, the insider now owns 45,992 shares in the company, valued at approximately $2,248,548.88. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.19% of the company’s stock.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.